Vascular pathology in dermatomyositis and anatomic relations to myopathology

Muscle and Nerve

Volumn 42, Issue 1, 2010, Pages 53-61

  Pestronk, Alan ^a   Schmidt, Robert E ^a   Choksi, Rati ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Capillary; Dermatomyositis; Immune; Muscle; Vessel

Indexed keywords

CD31 ANTIGEN; COMPLEMENT MEMBRANE ATTACK COMPLEX;

ADOLESCENT; ADULT; ARTICLE; BLOOD VESSEL INJURY; CHILD; COMPLEMENT DEPOSITION; CONNECTIVE TISSUE; CONTROLLED STUDY; DERMATOMYOSITIS; HUMAN; HUMAN TISSUE; ISCHEMIA; MUSCLE ATROPHY; MUSCLE CAPILLARY; MUSCLE DISEASE; PATHOLOGICAL ANATOMY; PERICYTE; PERIMYSIUM; PRIORITY JOURNAL; ULTRASTRUCTURE; VASCULAR DISEASE; VASCULITIS;

ADOLESCENT; ADULT; ANTIGENS, CD31; BIOPSY; BLOOD VESSELS; CAPILLARIES; CHILD; CHILD, PRESCHOOL; COLLAGEN TYPE IV; COMPLEMENT MEMBRANE ATTACK COMPLEX; DERMATOMYOSITIS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA;

EID: 77954122802     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21651     Document Type: Article

References (27)

1. Krathen MS, Fiorentino D, Werth VP. Dermatomyositis. Curr Dir Autoimmun 2008;10:313-332.
2. Feldman BM, Rider LG, Reed AM, Pachman LM. Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet 2008;371:2201-2212.
3. Emslie-Smith AM, Engel AG. Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann Neurol 1990;27:343-356.
4. Kissel JT, Mendell JR, Rammohan KW. Microvascular deposition of complement membrane attack complex in dermatomyositis. N Engl J Med 1986;314:329-334.
5. Miles L, Bove KE, Lovell D, Wargula JC, Bukulmez H, Shao M, et al. Predictability of the clinical course of juvenile dermatomyositis based on initial muscle biopsy: a retrospective study of 72 patients. Arthritis Rheum 2007;57:1183-1191.
6. Wedderburn LR, Varsani H, Li CKC, Newton KR, Amato AA, Banwell B, et al. International consensus on a proposed score system for muscle biopsy evaluation in patients with JDM, for potential use in clinical trials. Arthritis Rheum 2007;57:1192-1201.
7. Greenberg SA. Proposed immunologic models of the inflammatory myopathies and potential therapeutic implications. Neurology 2007;69:2008-2019.
8. Alhatou MI, Sladky JT, Bagasra O, Glass JD. Mitochondrial abnormalities in dermatomyositis: characteristic pattern of neuropathology. J Mol Histol 2004;35:615-619. (Pubitemid 41404647)
9. Pestronk A. Muscle biopsy. Neuromuscular Disease Center: http://neuromuscular.wustl.edu/pathol/dermmyo.htm#pfmito (accessed November 2009).
10. Mozaffar T, Pestronk A. Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres. J Neurol Neurosurg Psychiatry 2000;68:472-478. (Pubitemid 30248747)
11. Pestronk A. Muscle biopsy. Neuromuscular Disease Center: http://neuromuscular.wustl.edu/pathol/jo1.htm (accessed November 2009).
12. Pestronk A.Muscle biopsy. Neuromuscular Disease Center: http://neuromuscular.wustl.edu/lab/mbiopsy.htm#stain (accessed November 2009).
13. Pestronk A, Kos K, Lopate G, Al-Lozi MT. Brachio-cervical inflammatory myopathies: clinical, immune, and myopathologic features. Arthritis Rheum 2006;54:1687-1696.
14. Carpenter S, Karpati G. Pathology of skeletal muscle. New York: Oxford University Press; 2001. p 557.
15. Dubowitz V, Sewry CA. Muscle biopsy. A practical approach, 3rd ed. Philadelphia: Saunders Elsevier; 2007. p 530.
16. Dalakas MC, Illa I, Dambrosia JM, Soueidan SA, Stein DP, Otero C, et al. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 1993;329:1993-2000. (Pubitemid 24015043)
17. Batten FE. Case of dermato-myositis in a child, with pathologic report. Proc R Soc Med 1912;5:103-114.
18. Boylan RC, Sokoloff L. Vascular lesions in dermatomyositis. Arthritis Rheum 1960;3:379-386.
19. Wargula JC, Lovell DJ, Passo MH, Bove KE, Santangelo JD, Levinson JE. What more can we learn from muscle histopathology in children with dermatomyositis/polymyositis? Clin Exp Rheumatol 2006;24:333-343.
20. López De Padilla CM, Vallejo AN, Lacomis D, McNallan K, Reed AM. Extranodal lymphoid microstructures in inflamed muscle and disease severity of new-onset juvenile dermatomyositis. Arthritis Rheum 2009;60:1160-1172.
21. Belden JR, Caplan LR, Pessin MS, Kwan E. Mechanisms and clinical features of posterior border-zone infarcts. Neurology 1999;53:1312-1318.
22. Grundtman C, Tham E, Ulfgren AK, Lundberg IE. Vascular endothelial growth factor is highly expressed in muscle tissue of patients with polymyositis and patients with dermatomyositis. Arthritis Rheum 2008;58:3224-3238.
23. van Laake LW, van den Driesche S, Post S, Feijen A, Jansen MA, Driessens MH, et al. Endoglin has a crucial role in blood cell-mediated vascular repair. Circulation 2006;114:2288-2297.
24. Lebrin F, Mummery CL. Endoglin-mediated vascular remodeling: mechanisms underlying hereditary hemorrhagic telangiectasia. Trends Cardiovasc Med 2008;18:25-32.
25. Bourdeau A, Dumont DJ, Letarte M. A murine model of hereditary hemorrhagic telangiectasia. J Clin Invest 1999;104:1343-1351.
26. Pipinos II, Swanson SA, Zhu Z, Nella AA, Weiss DJ, Gutti TL, et al. Chronically ischemic mouse skeletal muscle exhibits myopathy in association with mitochondrial dysfunction and oxidative damage. Am J Physiol Regul Integr Comp Physiol 2008;295:R290-296.
27. Salajegheh M, Kong SW, Pinkus JL, Walsh RJ, Liao A, Nazareno R, et al. Interferon-stimulated gene 15 (ISG15) conjugates proteins in dermatomyositis muscle with perifascicular atrophy. Ann Neurol (in press).